Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.39 USD
Change Today -0.0149 / -3.68%
Volume 1.0K
REPR On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

repro medsystems inc (REPR) Snapshot

Open
$0.39
Previous Close
$0.41
Day High
$0.39
Day Low
$0.39
52 Week High
10/6/14 - $0.67
52 Week Low
07/18/14 - $0.26
Market Cap
14.8M
Average Volume 10 Days
8.5K
EPS TTM
$0.02
Shares Outstanding
38.0M
EX-Date
--
P/E TM
19.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for REPRO MEDSYSTEMS INC (REPR)

Related News

No related news articles were found.

repro medsystems inc (REPR) Related Businessweek News

No Related Businessweek News Found

repro medsystems inc (REPR) Details

Repro Med Systems, Inc. designs, manufactures, and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications worldwide. It offers FREEDOM60, a syringe infusion system for ambulatory medication infusions. The company provides FREEDOM60 for use in the infusion of specialized drugs, such as immunoglobulin G, pain control, and chemotherapy. It also offers RMS HIgH-Flo subcutaneous safety needle sets for self-administration of medicine under the skin; and RES-Q-VAC portable medical suction system, a portable and hand-operated suction device that removes fluids from a patient’s airway by attaching the RES-Q-VAC pump to various proprietary sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The company sells its products directly to physician offices, hospitals, and other institutional customers, as well as through a network of medical device distributors in the hospital respiratory care market. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

75 Employees
Last Reported Date: 05/8/15
Founded in 1980

repro medsystems inc (REPR) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $408.3K
Chief Financial Officer and Treasurer
Total Annual Compensation: $30.4K
Director of Administration
Total Annual Compensation: $135.0K
Compensation as of Fiscal Year 2015.

repro medsystems inc (REPR) Key Developments

Repro Med Products, Inc. Appoints Arthur J. Radin as Additional Member of the Board

On January 29, 2015, Arthur J. Radin, CPA, has been appointed as an additional member of the Board of Directors of Repro Med Products Inc. Mr. Radin, who started his career at Touche Ross & Co., has been a partner in public accounting firms for over 50 years. He was with Radin, Glass & Co. from 1998 until January 2015 when he joined Janover LLC. He is a member of the New York State Society of Certified Public Accountants Editorial Board.

Repro-Med Systems Inc. Announces Executive Changes

On January 19, 2015, Repro Med Systems Inc. announced that Karen Fisher will serve as Chief Financial Officer of RMS effective January 28, 2015. Ms. Fisher succeeds Barry Short, who served as Interim Chief Financial Officer from June 9, 2014, and remains as Director of Administration. Ms. Fisher, has more than 18 years of financial experience at a variety of industries, most recently serving as Assistant Controller, Senior Manager for Armored Autogroup Inc. from February 2012 to January 2015. Ms. Fisher is a Certified Public Accountant.

Repro-Med Systems Inc. Announces Revenue Results for the Third Quarter and Nine Months Ended November 30, 2014

Repro-Med Systems Inc. announced revenue results for the third quarter and nine months ended November 30, 2014. For the year-to-date, the company's net revenues were up 28.6% compared with last year, led by its line of home infusion products, while third quarter net revenues for fiscal 2015 increased 21.8% from fiscal 2014. Revenues for the quarter were $2,654,900 compared with $2,180,000 for the third quarter of fiscal 2014. In addition to representing a 21.8% increase year over year, the third quarter results for fiscal 2015 show a 6% increase over second quarter revenues of $2,505,900.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REPR:US $0.39 USD -0.0149

REPR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ambu A/S kr172.00 DKK +0.50
View Industry Companies
 

Industry Analysis

REPR

Industry Average

Valuation REPR Industry Range
Price/Earnings 20.2x
Price/Sales 1.4x
Price/Book 2.5x
Price/Cash Flow 14.8x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REPRO MEDSYSTEMS INC, please visit www.repro-med.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.